$0.05 EPS Expected for Kinross Gold (K); Laboratory Of America Holdings (LH)’s Sentiment Is 1.2

April 12, 2018 - By Ellis Scott

Kinross Gold Corporation (TSE:K) Logo

Analysts expect Kinross Gold Corporation (TSE:K) to report $0.05 EPS on May, 1.They anticipate $0.02 EPS change or 66.67% from last quarter’s $0.03 EPS. T_K’s profit would be $62.50M giving it 23.90 P/E if the $0.05 EPS is correct. After having $0.02 EPS previously, Kinross Gold Corporation’s analysts see 150.00% EPS growth. The stock increased 3.24% or $0.15 during the last trading session, reaching $4.78. About 6.52 million shares traded or 90.92% up from the average. Kinross Gold Corporation (TSE:K) has 0.00% since April 12, 2017 and is . It has underperformed by 11.55% the S&P500.

Laboratory Corp Of America Holdings (LH) investors sentiment increased to 1.2 in Q4 2017. It’s up 0.30, from 0.9 in 2017Q3. The ratio is positive, as 293 institutional investors increased and opened new holdings, while 245 sold and reduced their stock positions in Laboratory Corp Of America Holdings. The institutional investors in our database reported: 91.47 million shares, down from 91.79 million shares in 2017Q3. Also, the number of institutional investors holding Laboratory Corp Of America Holdings in top ten holdings decreased from 14 to 13 for a decrease of 1. Sold All: 36 Reduced: 209 Increased: 220 New Position: 73.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $16.75 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 13.45 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Since January 1, 0001, it had 0 insider purchases, and 5 insider sales for $10.55 million activity.

Veritas Investment Management Llp holds 6.79% of its portfolio in Laboratory Corporation of America Holdings for 307,591 shares. Bridger Management Llc owns 633,162 shares or 6.67% of their US portfolio. Moreover, Healthinvest Partners Ab has 5.99% invested in the company for 17,800 shares. The New York-based Healthcor Management L.P. has invested 5.71% in the stock. Allen Investment Management Llc, a New York-based fund reported 769,875 shares.

The stock decreased 0.59% or $0.97 during the last trading session, reaching $164.17. About 479,318 shares traded. Laboratory Corporation of America Holdings (LH) has risen 14.17% since April 12, 2017 and is uptrending. It has outperformed by 2.62% the S&P500.

Analysts await Laboratory Corporation of America Holdings (NYSE:LH) to report earnings on April, 24. They expect $2.65 earnings per share, up 19.37% or $0.43 from last year’s $2.22 per share. LH’s profit will be $270.31M for 15.49 P/E if the $2.65 EPS becomes a reality. After $2.45 actual earnings per share reported by Laboratory Corporation of America Holdings for the previous quarter, Wall Street now forecasts 8.16% EPS growth.

Among 6 analysts covering Kinross Gold Corporation (TSE:K), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 50% are positive. Kinross Gold Corporation had 23 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of Kinross Gold Corporation (TSE:K) has “Sector Perform” rating given on Friday, February 17 by Scotia Capital. Scotia Capital maintained Kinross Gold Corporation (TSE:K) rating on Thursday, November 3. Scotia Capital has “Sector Perform” rating and $8.50 target. The rating was upgraded by BMO Capital Markets to “Outperform” on Monday, May 29. The company was upgraded on Tuesday, November 24 by RBC Capital Markets. The stock of Kinross Gold Corporation (TSE:K) has “Sell” rating given on Monday, December 11 by Desjardins Securities. The firm has “Outperform” rating given on Friday, September 23 by RBC Capital Markets. The firm earned “Neutral” rating on Thursday, February 4 by JP Morgan. The stock of Kinross Gold Corporation (TSE:K) earned “Sector Perform” rating by Scotia Capital on Friday, May 5. RBC Capital Markets maintained Kinross Gold Corporation (TSE:K) on Friday, August 26 with “Outperform” rating.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>